Delivery Order SPE2DB20D7059-SPE2DB24FQLQ9

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,000.83 Firm Fixed Price delivery order covers the supply of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML, a medical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $5,933.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a prescription drug product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Liraglutide 2-Pak 18 mg/3 ml 3 ml. The award, valued at $2,735.68, is a Delivery Order that will be completed by August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award, valued at $26,405.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,096.32, is for the delivery of Liraglutide 3-pak 18 mg/3 ml medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,117.95 firm fixed-price delivery order is for the supply of Liraglutide 3-Pak 18 mg/3 ml 3ml medication. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,281.33 firm fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The award has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,314.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,241.82, is for the delivery of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a Firm Fixed Price agreement. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,780.09 firm-fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQLQ9
    Delivery Order

This federal contract award with ID SPE2DB20D7059|SPE2DB24FQLQ9 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LIRAGLUTIDE 2-PAK 18 MG/3 ML 3ML. The contract has a ceiling value of $1,053.30 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 26, 2024. This award does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation. These contract vehicles enable the government to efficiently procure essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/22/24, 9:56 AM